- Home
- / Jiangxi Fushine Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jiangxi Fushine Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥11.4
2024-10-29
Market Capitalization
¥6.4 B
2024-10-29
Revenue
¥1.2 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.3B | 1.5B | 1.4B | 1.6B | 1.6B | 1.2B |
| Cost of goods sold | 730.0M | 770.3M | 889.2M | 993.6M | 1.4B | 1.4B | 1.1B |
| Gross profit | 421.0M | 570.1M | 588.8M | 421.4M | 281.9M | 154.4M | 97.2M |
| Gross profit margin, % | 36.7% | 42.9% | 39.9% | 30.7% | 17.4% | 9.8% | 8.4% |
| Operating expense total | 109.4M | 110.4M | 112.8M | 94.7M | 136.5M | 123.1M | 46.0M |
| Depreciation and amortization | 61.1M | 74.4M | 73.3M | 96.5M | 126.4M | 178.5M | 266.5M |
| EBITDA | 305.2M | 452.9M | 460.9M | 275.0M | 142.2M | 17.0M | 36.4M |
| EBITDA margin, % | 26.6% | 34.0% | 31.2% | 20.0% | 8.8% | 1.1% | 3.1% |
| EBIT | 240.0M | 386.7M | 421.8M | 117.1M | (139.2M) | (191.1M) | (248.3M) |
| EBIT margin, % | 20.9% | 29.1% | 28.6% | 8.5% | -8.6% | -12.1% | -21.5% |
| Interest income | 7.1M | 9.7M | 14.7M | 16.4M | 23.3M | 9.3M | 6.7M |
| Interest expense | 24.1M | 33.1M | 23.7M | 24.9M | 41.1M | 42.0M | 40.6M |
| Pre tax profit | 227.1M | 358.4M | 378.8M | 55.1M | (142.7M) | (233.2M) | (288.6M) |
| Income tax expense | 34.7M | 51.5M | 56.6M | 15.5M | 21.5M | (9.9M) | (8.1M) |
| Net Income | 192.4M | 306.9M | 322.2M | 39.5M | (164.2M) | (223.3M) | (280.5M) |